Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Cox

Showing results (171-180 of 208) with videos related to

Pageof 21
Sort By:
Molecular Metabolism|March 12, 2021
Selective release of gastrointestinal hormones induced by an orally active GPR39 agonistKaare V Grunddal, Thi A Diep, Natalia Petersen, et al.
Neurology|April 1, 2016
Diffuse hypomyelination is not obligate for POLR3-related disordersRoberta La Piana, Ferdy K Cayami, Luan T Tran, et al.
The Lancet. Global Health|January 27, 2019
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysisGian Luca Di Tanna, Ali Raza Khaki, Grant Theron, et al.
Human Mutation|January 15, 2013
Genotype-phenotype correlations emerging from the identification of missense mutations in MBTPS2Dorothea Bornholdt, T Prescott Atkinson, Bakar Bouadjar, et al.
The Journal of Infectious Diseases|April 13, 2012
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunitiesRuth McNerney, Markus Maeurer, Ibrahim Abubakar, et al.
The Lancet. Infectious Diseases|March 28, 2013
Drug-resistant tuberculosis: time for visionary political leadershipIbrahim Abubakar, Matteo Zignol, Dennis Falzon, et al.
BMC Infectious Diseases|August 15, 2024
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)Chacha Mangu, Marta Cossa, Robert Ndege, et al.
The Lancet. Infectious Diseases|May 9, 2026
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trialMarta Cossa, Robert Ndege, Bindiya Meggi, et al.
Elife|April 18, 2017
Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expressionNuno Rocha, David A Bulger, Andrea Frontini, et al.
The European Respiratory Journal|September 3, 2016
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological methodCarole D Mitnick, Richard A White, Chunling Lu, et al.
Pageof 21

Showing results (171-180 of 208) with videos related to

Sort By:
Pageof 21
Molecular Metabolism|March 12, 2021
Selective release of gastrointestinal hormones induced by an orally active GPR39 agonistKaare V Grunddal, Thi A Diep, Natalia Petersen, et al.
Neurology|April 1, 2016
Diffuse hypomyelination is not obligate for POLR3-related disordersRoberta La Piana, Ferdy K Cayami, Luan T Tran, et al.
The Lancet. Global Health|January 27, 2019
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysisGian Luca Di Tanna, Ali Raza Khaki, Grant Theron, et al.
Human Mutation|January 15, 2013
Genotype-phenotype correlations emerging from the identification of missense mutations in MBTPS2Dorothea Bornholdt, T Prescott Atkinson, Bakar Bouadjar, et al.
The Journal of Infectious Diseases|April 13, 2012
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunitiesRuth McNerney, Markus Maeurer, Ibrahim Abubakar, et al.
The Lancet. Infectious Diseases|March 28, 2013
Drug-resistant tuberculosis: time for visionary political leadershipIbrahim Abubakar, Matteo Zignol, Dennis Falzon, et al.
BMC Infectious Diseases|August 15, 2024
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)Chacha Mangu, Marta Cossa, Robert Ndege, et al.
The Lancet. Infectious Diseases|May 9, 2026
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trialMarta Cossa, Robert Ndege, Bindiya Meggi, et al.
Elife|April 18, 2017
Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expressionNuno Rocha, David A Bulger, Andrea Frontini, et al.
The European Respiratory Journal|September 3, 2016
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological methodCarole D Mitnick, Richard A White, Chunling Lu, et al.
Pageof 21